Latigo Biotherapeutics
CA - Thousand OaksBiotechnology
Focus: Latigo Biotherapeutics is a Series B biotechnology company focused on developing non-opioid pain relief therapeutics, headquartered in Thousand Oaks, California. The company is pursuing a Nasdaq IPO to fund advancement of its novel pain management pipeline.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES B
Open Jobs
20-2 this month
Stable — net -2 jobs in 30d
4 added, 6 removed. Backfill posture.
Should You Work at Latigo Biotherapeutics?
AI assessmentHigh-risk, high-reward opportunity best suited for mission-driven professionals comfortable with clinical-stage volatility and willing to bet on IPO success.
Why Work Here
- Pre-IPO equity upside: company filed for Nasdaq IPO in July 2026, offering early-stage employees potential liquidity events and ownership stakes
- High-impact therapeutic area: non-opioid pain relief addresses a $10B+ market gap with direct competitive positioning against established players like Vertex (Journax)
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LTG-001 SDD
Pain ManagementClinical Trials (1)
NCT07341152A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants
Phase 1Help build intelligence for Latigo Biotherapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.